USPTO serial 75589067
LORUS
Reviewed by CopyMark Law Group
Reg. 2751563Status 710
- Filing date
- Status date
- Registration date
- Aug 19, 2003
- Examiner
- EDWARDS, ALICIA COLLINS
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LORUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Scarborough, Ontario M1B 3W2, CA
MARKHAM, ONTARIO, CA
MARKHAM, ONTARIO, CA
MARKHAM, ONTARIO, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SAMSON HELFGOTT
LINDA S CHAN KATTEN MUCHIN ZAVIS ROSENMAN575 MADISON AVENEW YORK, NY 10022-2585UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASE AND NEUROLOGICAL DISEASES | SECTION 8 - CANCELLED | — |
| 035 | PREPARING BUSINESS REPORTS FOR REGULATORY AGENCIES IN THE FORM OF REGULATORY FILINGS; COMPUTERIZED DATABASE MANAGEMENT OF DATA FROM STUDY CASE RECORD FORMS AND FROM OTHER CLINICAL SOURCES; BUSINESS REGULATORY CONSULTATION; BUSINESS CONSULTATION IN THE FIELD OF MANUFACTURING, NAMELY, CONDUCTING MOCK FDA MANUFACTURING AUDITS | SECTION 8 - CANCELLED | — |
| 040 | CUSTOM MANUFACTURE OF BIOTECHNOLOGY PRODUCTS AND PHARMACEUTICAL PREPARATIONS FOR CLIENTS | SECTION 8 - CANCELLED | — |
| 042 | CLINICAL RESEARCH SERVICES FOR OTHERS, NAMELY, PERFORMING SCIENTIFIC RESEARCH FOR CLIENTS IN THE AREAS OF HUMAN AND ANIMAL DISEASES, NAMELY CANCER AND INFECTIOUS DISEASES AND NEUROLOGICAL DISEASES; BIOLOGICAL AND CLINICAL PHARMACEUTICAL TESTING SERVICES; TECHNICAL WRITING FOR OTHERS, NAMELY PREPARATION OF MEDICAL RESEARCH REPORTS IN THE FIELD OF CLINICAL PHARMACEUTICAL AND BIOLOGICAL TESTING; DESIGN AND DEVELOPMENT OF PLANS FOR BIOTECHNOLOGY PRODUCTS AND DEVICES; MEDICAL TESTING, NAMELY, MONITORING OF PRE-CLINICAL AND CLINICAL STUDIES; MEDICAL SERVICES, NAMELY, SELECTION OF CLINICAL AND PRE-CLINICAL STUDY SITES; BIOSTATISTICAL CONSULTING AND ANALYSIS OF BIOSTATISTICAL DATA; LEGAL REPRESENTATION OF CLIENTS WITH REGULATORY AUTHORITIES | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IMUTEC PHARMA INC.
- Other trademarks owned by LORUS THERAPEUTICS INC.
- Other trademarks owned by LORUS THERAPEUTICS INC.
- Other trademarks owned by LORUS THERAPEUTICS INC.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named LORUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2010 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 9, 2008 | CFIT | CASE FILE IN TICRS | — |
| Sep 5, 2007 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 19, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 5, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| May 20, 2003 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 27, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 21, 2003 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Jan 21, 2003 | PAPER RECEIVED | — | |
| Jan 16, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 2, 2002 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Apr 2, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 8, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 29, 2001 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jun 27, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 2001 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jul 17, 2000 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jan 14, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 1999 | DOCK | ASSIGNED TO EXAMINER | — |